Praxis Precision Medicines, Inc. (PRAX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Praxis Precision Medicines, Inc. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $937.91M in total assets against $59.77M in total liabilities.
Key ratios (FY2025)
-34.5%
Return on equity
-100.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $8.55M | $2.45M | $0 | — | — | — | — |
| Operating Income | -$326.20M | -$200.16M | -$126.37M | -$214.99M | -$167.33M | -$61.97M | -$35.79M | — |
| Net Income | -$303.27M | -$182.82M | -$123.28M | -$214.03M | -$167.06M | -$61.82M | -$35.51M | — |
| EPS (Diluted) | $-13.48 | $-10.21 | $-18.69 | $-69.65 | $-3.94 | $-7.86 | — | — |
| Total Assets | $937.91M | $483.11M | $87.95M | $115.13M | $292.75M | $303.18M | $47.69M | — |
| Total Liabilities | $59.77M | $37.66M | $18.28M | $39.02M | $41.94M | $15.72M | $7.58M | — |
| Shareholders' Equity | $878.14M | $445.45M | $69.67M | $76.11M | $250.81M | $287.46M | -$81.01M | -$41.04M |
| Cash & Equivalents | $357.33M | $215.37M | $81.30M | $61.62M | $138.70M | $296.61M | $44.81M | — |
| Operating Cash Flow | -$249.07M | -$131.76M | -$111.14M | -$185.04M | -$124.55M | -$52.62M | -$33.42M | — |
| Capital Expenditures | $56.0K | $0 | $50.0K | $444.0K | $1.05M | $0 | $103.0K | — |
| Shares Outstanding | 25.20M | 19.42M | 8.79M | 3.29M | 45.30M | 38.27M | 1.62M | — |